Use Of A Phospholipid-Containing Composition For The Removal Of Subcutaneous Fat Accumulations By Subcutaneous Lipolysis
AssigneeLichtblick SE
InventorsKarl-Josef Gundermann, Dirk Brandl
Life of this patent
Estimating the term…
Abstract
The invention described herein relates to the use of an aqueous composition containing at least one phospholipid. at least one glycyrrhizic acid or salts of glycyrrhizic acid for the manufacture of mediciments for the removal of subcutaneous fat accumulation.
Claims17
1-16. (canceled)
A method for the non-surgical removal of a subcutaneous fat accumulation from a patient, the method comprising:
- providing a composition comprising one or more phospholipids and one or more of glycyrrhizic acid and its salts, wherein the total content of the one or more phospholipids and the one or more of glycyrrhizic acid and its salts in the composition is 2-80 weight percent, and wherein the weight ratio between the one or more phospholipids and the one or more of glycyrrhizic acid and its salts is from 30:1 to 0.5:1;
- and
- administering an amount of the composition to the patient sufficient to non-surgically remove the subcutaneous fat accumulation from the patient.
A method for the non-surgical treatment of a subcutaneous adipose tissue disorder with local disturbance of fat distribution in a patient, the method comprising:
- providing a composition comprising one or more phospholipids and one or more of glycyrrhizic acid and its salts, wherein the total content of the one or more phospholipids and the one or more of glycyrrhizic acid and its salts in the composition is 2-80 weight percent, and wherein the weight ratio between the one or more phospholipids and the one or more of glycyrrhizic acid and its salts is from 30:1 to 0.5:1;
- and
- administering an amount of the composition to the patient sufficient to non-surgically remove a subcutaneous fat accumulation from the patient.
A method for the degradation and degeneration of an adipose tissue tumor in a patient, the method comprising:
- providing a composition comprising one or more phospholipids and one or more of glycyrrhizic acid and its salts, wherein the total content of the one or more phospholipids and the one or more of glycyrrhizic acid and its salts in the composition is 2-80 weight percent, and wherein the weight ratio between the one or more phospholipids and the one or more of glycyrrhizic acid and its salts is from 30:1 to 0.5:1;
- and
- administering an amount of the composition to the patient sufficient to non-surgically degrade and degenerate the adipose tissue tumor in the patient.
Dependencies are inferred from the claim text.